Ritedose Partners with Newberry College to Launch Leadership Development Program
Organizational development and pharmaceutical leadership certificate is designed to strengthen organizational leadership at Ritedose
READ MORE
IN THE NEWS
Press Releases
Ritedose Opens Advanced Laboratory and Expands Analytical Capabilities to Accelerate Pharmaceutical Innovation—Positioning the Company as a Preferred Partner for Drug Development and Manufacturing
– Triples laboratory footprint with the $17 million investment. – Features new leachables and extractables testing capabilities. – Allows for seamless development and manufacturing experience while supporting pharmaceutical products throughout entire lifecycle. – Creates an integrated laboratory infrastructure coupled with…
READ MORE
Ritedose Positioned to Support Hospitals with Reliable and Quality Albuterol Inhalation Solution, USP 0.5% (Albuterol Concentrate) Supply
– Ritedose expands albuterol inhalation solution production and strengthens its role as a trusted source for inhaled solutions. – The Company ramped up multiple albuterol inhalation solution strengths during national shortage, reinforcing its role as a trusted source for inhaled…
READ MORE
Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth
The role will focus on identifying new opportunities and strengthening existing customer relationships to accelerate Ritedose’s continued growth.
READ MORE
Ritedose Commits to National “Hope Alliance” Campaign to Support Uninsured Patients
The leader in unit dose sterile medications pledges to the Dispensary of Hope a long-term supply of critical respiratory medications to stabilize care for vulnerable populations.
READ MORE
Ritedose Reaches “1,000 Hours of Purpose”
Employee-led initiative deepens Ritedose’s commitment to Midlands nonprofits and the communities they serve.
READ MORE
Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing
– Collaboration showcases the Ritedose Center of Excellence as a global hub for advanced manufacturing education. – The Center of Excellence serves as a cornerstone of Ritedose’s broader commitment to workforce development and industry leadership.
READ MORE
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic Treatment.
READ MORE
Ritedose Honored With SCbio’s 2026 Life Sciences Pinnacle Award for Organizational Contribution
South Carolina’s largest sterile CDMO recognized for visionary leadership, innovation, and community impact at SCbio’s annual Life + Science Conference.
READ MORE
A Season of Gratitude and Purpose: A Thanksgiving Message from Jody Chastain, CEO of Ritedose
Ritedose has been built on the generosity, mentorship, and support of countless individuals and organizations across South Carolina. And with that good fortune comes a responsibility to give back to our patients, our people, and our community.
READ MORE
Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution
The Ritedose Corporation (Ritedose) announced that the U.S. Food and Drug Administration (FDA) approved its manufacturing and distribution of Tobramycin Inhalation Solution to treat patients six years and older with infections of Pseudomonas aeruginosa, a common bacterial infection among cystic…
READ MORE
Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position
Ritedose is investing $17M to expand its cGMP labs, adding a 10,000 sq. ft. analytical chemistry facility and a 6,000 sq. ft. microbiology expansion to boost drug development and CDMO capabilities.
READ MORE
FEATURED NEWS
RECEIVE THE LATEST NEWS
Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.